Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Fesoterodine
Drug ID BADD_D00891
Description Fesoterodine is an antimuscarinic prodrug for the treatment of overactive bladder syndrome.
Indications and Usage For the treatment of overactive bladder (with symptoms of urinary frequency, urgency, or urge incontinence).
Marketing Status Prescription; Discontinued
ATC Code G04BD11
DrugBank ID DB06702
KEGG ID D07226
MeSH ID C526675
PubChem ID 6918558
TTD Drug ID D00BLL
NDC Product Code 47621-025; 50370-0047
Synonyms fesoterodine | toviaz | fesoterodine fumarate
Chemical Information
Molecular Formula C26H37NO3
CAS Registry Number 286930-02-7
SMILES CC(C)C(=O)OC1=C(C=C(C=C1)CO)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Generalised oedema14.05.06.007; 08.01.07.0040.003411%
Glaucoma06.03.01.0020.002274%
Glossodynia07.14.02.0010.002274%Not Available
Haematuria24.07.01.047; 20.02.01.0060.003411%
Blood urine present13.13.02.0020.002274%Not Available
Hallucination19.10.02.0020.005685%
Headache17.14.01.001--
Heart rate irregular13.14.04.0030.002274%Not Available
Hepatic function abnormal09.01.02.0010.003411%Not Available
Hip fracture12.04.01.001; 15.08.03.0010.003411%
Hydronephrosis20.01.05.0010.004548%Not Available
Hypersensitivity10.01.03.003--
Hypertension24.08.02.001--
Hypertonic bladder20.03.03.003; 17.10.01.0030.002274%Not Available
Hypokalaemia14.05.03.0020.002274%
Hyponatraemia14.05.04.0020.003411%
Hypotension24.06.03.002--
Ileus07.13.01.0010.009096%
Impaired gastric emptying07.02.02.0040.002274%
Incontinence20.02.02.004; 17.05.01.006; 07.01.06.0110.002274%Not Available
Infection11.01.08.002--Not Available
Influenza22.07.02.001; 11.05.03.001--Not Available
Insomnia19.02.01.002; 17.15.03.002--
Interstitial lung disease22.01.02.003; 10.02.01.0330.002274%Not Available
Intestinal obstruction07.13.01.0020.007959%Not Available
Intraocular pressure increased13.07.04.0020.003411%Not Available
Irritable bowel syndrome19.24.01.003; 07.02.04.003--Not Available
Laryngeal pain22.02.05.036--
Lip swelling23.04.01.007; 10.01.05.005; 07.05.04.0050.003411%Not Available
Malaise08.01.01.0030.022740%
The 4th Page    First    Pre   4 5 6 7 8    Next   Last    Total 8 Pages